Emerging Triglyceride-Rich Lipoprotein Targeted Therapies: An Unmet Need in Cardiometabolic Disease

<b>Background/Objectives</b>: Hypertriglyceridemia (HTG) is a common multifactorial metabolic disorder often with genetic predisposition. Multiple lines of evidence support a causal role of triglyceride-rich lipoproteins (TRLs) in atherosclerotic cardiovascular disease (ASCVD), with seve...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Jorge Ferreira, Miguel Domingues, António Ferreira
Format:	Article
Language:	English
Published:	MDPI AG 2025-08-01
Subjects:	angiopoietin-like 3 apolipoprotein C-III atherosclerotic cardiovascular disease hypertriglyceridemia triglyceride-rich lipoprotein
Online Access:	https://www.mdpi.com/1999-4923/17/9/1107